Skip to content

Transcutaneous CO2 monitoring in Paediatric Endoscopy

Transcutaneous CO2 monitoring in Paediatric Endoscopic procedures as an early marker for alveolar hypoventilation. A prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027649
Enrollment
152
Registered
2020-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

None listed

Sponsors

Badal Parikh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologists Class I or II Scheduled for endoscopic procedures

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The primary objective is to determine whether Transcutaneous CO2 monitoring in paediatric patients undergoing endoscopic procedures predicts severe hypoventilation Timepoint: Transcutaneous monitoring will be initiated 5 minutes before administration of sedative agents and continue until at least 10 minutes after final withdrawal of the endoscope

Secondary

MeasureTime frame
Secondary objective is to assess the accuracy of Transcutaneous CO2 with PaCO2 in paediatric patientsTimepoint: Transcutaneous monitoring will be initiated 5 minutes before administration of sedative agents and continue until at least 10 minutes after final withdrawal of the endoscope

Countries

India

Contacts

Public ContactBadal Parikh

Army Hospital (R and R)

drbadalparikh@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026